For low-to-intermediate-risk prostate cancer patients and older patients, observation with – in case of biochemical recurrence – early salvage radiotherapy can be advised after R0 resection ...

It was prostate cancer. Bill says, “I received radiation therapy and treatments ... Schwen said Sedivy was a perfect ...

Following radical prostatectomy, success of adjuvant and salvage radiation therapy (RT ... is prognostic in metastatic prostate cancer. We hypothesize that CTCs may also be prognostic in the ...

Patients with pT3N0M0 disease after radical prostatectomy for localized prostate cancer are at ... of immediate optimized radiation therapy, as described above, versus salvage radiation therapy ...

Actinium Pharmaceuticals Inc. has unveiled ATNM-400, a novel non-PSMA-targeting, first-in-class radiotherapy for prostate cancer utilizing the Actinium-225 (Ac-225) radioisotope.

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

Discover how isodose MHFRT offers comparable cancer control to CFRT with fewer gastrointestinal side effects, improving patient outcomes.

“In addition, prior postoperative radiation may have treated residual pelvic [prostate cancer] and select for ... PSMA PET/CT at PSA < 0.5 ng/mL for salvage treatment planning,” they concluded.

[99] A straight retrospective comparison with salvage (76 Gy ... age-related conditions, the cancer diagnosis and surgery have a stronger impact than radiotherapy (RT). In clinical trials subgroup ...